MS4A1 and lung carcinoma: In addition, high level of CD20, the specific marker for B cell, and B cell set in lung cancer was correlated with better overall survival in patients received chemotherapy, improved clinical outcomes of primary and follow-up treatments, and delayed tumor progression, respectively (Supplementary Figure S3).